Abstract:Background: The overall 5-year survival of lung cancer was reported to be only ~15%, with lung adenocarcinoma (LUAD) as the main pathological subtype. Before developing into invasive stages, LUAD undergoes pre-invasive stages of adenocarcinoma in situ (AIS) and minimally invasive adenocarcinoma (MIA), where surgical resection gives an excellent 5-year survival rate. Given the dramatic decline of prognosis from pre-invasive to invasive stages, a deeper understanding of key molecular changes driving the progression of LUAD is highly needed. Methods: In this study, we performed whole-exome sequencing and RNA sequencing on surgically resected 24 AIS, 74 MIA, 99 LUAD specimens, and their adjacent paired normal tissues. Survival data were obtained by follow-up after surgery. Key molecular events were found by comparing the gene expression profiles of tumors with different stages. Finally, to measure the level of imbalance between tumor intrinsic growth potential and immune microenvironment, a tumor progressive (TP) index was developed to predict tumor progression and patients' survival outcome and validated by external datasets. Results: As tumors progressed to more invasive stages, they acquired higher growth potential, mutational frequency of tumor suppressor genes, somatic copy number alterations, and tumor mutation burden, along with suppressed immune function. To better predict tumor progression and patients' outcome, TP index were built to measure the imbalance between tumor intrinsic growth potential and immune microenvironment. Patients with a higher TP index had significantly worse recurrence-free survival [Hazard ratio (HR), 10.47; 95% CI, 3.21–34.14; p < 0.0001] and overall survival (OS) [Hazard ratio (HR), 4.83e8; 95% CI, 0–Inf; p = 0.0013]. We used The Cancer Genome Atlas (TCGA)-LUAD dataset for validation and found that patients with a higher TP index had significantly worse OS (HR, 1.10; 95% CI, 0.83–1.45; p = 0.048), demonstrating the prognostic value of the TP index for patients with LUAD. Conclusions: The imbalance of tumor intrinsic growth potential and immune function orchestrate the progression of LUAD, which can be measured by TP index. Our study provided new insights into predicting survival of patients with LUAD and new target discovery for LUAD through assessing the imbalance between tumor intrinsic growth potential and immune function.

USF1 Promotes Lung Adenocarcinoma Progression by Regulating Neurotrophin Signaling Pathway

TKI Resistant-Based Prognostic Immune Related Gene Signature in LUAD, in Which FSCN1 Contributes to Tumor Progression.

NPM3 As a Novel Oncogenic Factor and Poor Prognostic Marker Contributes to Cell Proliferation and Migration in Lung Adenocarcinoma

miR-210-3p Promotes Lung Cancer Development and Progression by Modulating USF1 and PCGF3

USF1‐induced overexpression of long noncoding RNA WDFY3‐AS2 promotes lung adenocarcinoma progression via targeting miR‐491‐5p/ZNF703 axis

Elevated expression of Twinfilin-1 is correlated with inferior prognosis of lung adenocarcinoma

Ubiquitin specific peptidase 38 epigenetically regulates KLF transcription factor 5 to augment malignant progression of lung adenocarcinoma

Isospora belli enteritis in three homosexual men.

USP22 promotes development of lung adenocarcinoma through ubiquitination and immunosuppression

USP18 promotes colon adenocarcinoma progression via targeting the ERK-MNK signaling pathway

UPP1 promotes lung adenocarcinoma progression through the induction of an immunosuppressive microenvironment

USP53 Promotes Apoptosis and Inhibits Glycolysis in Lung Adenocarcinoma Through FKBP51‐AKT1 Signaling

FSCN1 Induced PTPRF-dependent Tumor Microenvironment Inflammatory Reprogramming Promotes Lung Adenocarcinoma Progression Via Regulating Macrophagic Glycolysis

FOXF1 inhibits invasion and metastasis of lung adenocarcinoma cells and enhances anti-tumor immunity via MFAP4/FAK signal axis

SP1 transcriptionally regulates UBE2N expression to promote lung adenocarcinoma progression

Localization of type 1 17beta-hydroxysteroid dehydrogenase mRNA and protein in syncytiotrophoblasts and invasive cytotrophoblasts in the human term villi.

NTSR1 promotes epithelial-mesenchymal transition and metastasis in lung adenocarcinoma through the Wnt/β-catenin pathway

UPF1 Increases Amino Acid Levels and Promotes Cell Proliferation in Lung Adenocarcinoma Via the Eif2α-Atf4 Axis

Deubiquitylase USP31 Induces Autophagy and Promotes the Progression in Lung Squamous Cell Carcinoma Cells by Stabilizing E2F1 Expression

Increased Tumor Intrinsic Growth Potential and Decreased Immune Function Orchestrate the Progression of Lung Adenocarcinoma

Mechanistic study of lncRNA UCA1 promoting growth and cisplatin resistance in lung adenocarcinoma